On February 24, 2026 Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, reported that company management will present at two upcoming investor conferences:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

TD Cowen 46th Annual Health Care Conference on Tuesday, March 3rd at 9:50 a.m. ET in Boston, MA.
Leerink Global Healthcare Conference on Monday, March 9th at 3:40 p.m. ET in Miami, FL.

Disc management will be participating in investor meetings during the above conferences, as well as the Jefferies Biotech on the Beach Summit on March 10th and the Barclays 28th Annual Global Healthcare Conference on March 11th, both in Miami, FL.

Live webcasts of the presentations will be available through the investor relations section of the Company’s website at ir.discmedicine.com and an archived replay will be available after the event.

(Press release, Disc Medicine, FEB 24, 2026, View Source [SID1234662906])